Overview: Soleno Therapeutics (NASDAQ: SLNO) is facing a securities-fraud class action lawsuit with...
Category - Investor Strategy
Market Madness: GameStop, Ethereum, Teva’s FDA Win
Good morning. It’s Tuesday, March 31, 2026. Here’s your unfiltered snapshot of what moved markets...
Deadline Alert: SLNO Shareholders, Act Now on Fraud Claims!
Introduction and Fraud Allegations Soleno Therapeutics (NASDAQ: SLNO), a biotech company focused on...
Brace for Bitcoin Squeeze and Biotech Volatility
Market Pulse: Bitcoin shorts have piled up as traders bet on a price drop, while FDA approvals...
SLNO: Urgent! Secure Counsel Before Deadline!
Company Overview and Recent Developments Soleno Therapeutics, Inc. (NASDAQ: SLNO) is a...
Morning Snapshot: Rocket Pharma Fallout Shakes Biotech
Morning Snapshot Market Pulse: Gene therapy news sent Rocket Pharma into a mid-teens slump...
Act Now: SLNO Investors Urged to Secure Counsel Before Deadline!
Introduction Soleno Therapeutics (NASDAQ: SLNO) is under the spotlight after a class-action lawsuit...
Market Morning Brief: Key Biotech Approvals Spark Volatility
Market Morning Brief Market Pulse: Regulatory decisions in Europe and the U.S. around obesity and...
SLNO Faces Class Action: What This Means for Investors
Company Overview: Soleno Therapeutics and Its Lead Product Soleno Therapeutics (NASDAQ: SLNO) is a...
Position Ahead of FDA Approval-Driven Biotech Rally
Daily Financial Update Market Pulse: Federal drug approvals have ignited biotech optimism, lifting...